<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "2: Additional ", fill: "#c0c0c0"},
{source: "2: Additional ", target: "2: uncertainties", fill: "#c0c0c0"},
{source: "2: uncertainties", target: "2: presently known", fill: "#c0c0c0"},
{source: "2: presently known", target: "2: immaterial also may impair", fill: "#c0c0c0"},
{source: "2: immaterial also may impair", target: "2: operations", fill: "#c0c0c0"},
{source: "2: Additional ", target: "6: cancellation", fill: "#c0362c"},
{source: "6: cancellation", target: "6: strategic alliance", fill: "#c0362c"},
{source: "6: strategic alliance", target: "6: significant customer", fill: "#c0362c"},
{source: "6: significant customer", target: "6: collaborative partner could also", fill: "#c0362c"},
{source: "6: collaborative partner could also", target: "6: adverse impact on", fill: "#c0362c"},
{source: "6: adverse impact on", target: "6: market price", fill: "#c0362c"},
{source: "6: market price", target: "6: common stock", fill: "#c0362c"},
{source: "6: cancellation", target: "8: electronic lab notebook software", fill: "#aaf0d1"},
{source: "8: electronic lab notebook software", target: "10: integration", fill: "#701c1c"},
{source: "10: integration", target: "10: integrated software products", fill: "#701c1c"},
{source: "10: integrated software products", target: "10: existing customers due", fill: "#701c1c"},
{source: "10: integration", target: "11: activities such as", fill: "#c66"},
{source: "11: activities such as", target: "11: development", fill: "#c66"},
{source: "11: development", target: "11: acquisition", fill: "#c66"},
{source: "11: acquisition", target: "11: technology could disrupt", fill: "#c66"},
{source: "11: technology could disrupt", target: "11: management team", fill: "#c66"},
{source: "11: management team", target: "11: two acquisitions", fill: "#c66"},
{source: "11: two acquisitions", target: "11: additional acquisitions", fill: "#c66"},
{source: "11: additional acquisitions", target: "11: exploit technology", fill: "#c66"},
{source: "11: exploit technology", target: "11: market opportunities", fill: "#c66"},
{source: "11: activities such as", target: "19: profitability", fill: "#ddadaf"},
{source: "19: profitability", target: "19: dependent on", fill: "#ddadaf"},
{source: "19: dependent on", target: "19: discoveries", fill: "#ddadaf"},
{source: "19: discoveries", target: "19: commercialize", fill: "#ddadaf"},
{source: "19: commercialize", target: "19: extend current collaboration research", fill: "#ddadaf"},
{source: "19: extend current collaboration research", target: "19: development arrangements", fill: "#ddadaf"},
{source: "19: development arrangements", target: "19: add new ones", fill: "#ddadaf"},
{source: "19: add new ones", target: "19: secure new", fill: "#ddadaf"},
{source: "19: secure new", target: "19: Symyx Tools ", fill: "#ddadaf"},
{source: "19: Symyx Tools ", target: "19: add additional licensees", fill: "#ddadaf"},
{source: "19: add additional licensees", target: "19: intellectual", fill: "#ddadaf"},
{source: "19: profitability", target: "26: technologies", fill: "#e30022"},
{source: "26: technologies", target: "26: methodologies", fill: "#e30022"},
{source: "26: methodologies", target: "26: royalties on", fill: "#e30022"},
{source: "26: royalties on", target: "26: products by", fill: "#e30022"},
{source: "26: products by", target: "26: partners until", fill: "#e30022"},
{source: "26: partners until", target: "26: commenced commercial sales", fill: "#e30022"},
{source: "26: commenced commercial sales", target: "26: products containing", fill: "#e30022"},
{source: "26: technologies", target: "START_HERE", fill: "#e30022"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Investment Banking and Brokerage</td>
    </tr>
    <tr>
      <td>Automobiles and Components</td>
    </tr>
    <tr>
      <td>Electrical Components and Equipment</td>
    </tr>
    <tr>
      <td>Electronic Equipment and Instruments</td>
    </tr>
    <tr>
      <td>Environmental Services</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Ease</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Crime</td>
    </tr>
    <tr>
      <td>Leadership</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Psychological state</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Yield position</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Endorse</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Empathize</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Seize</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Military blockade</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
    <tr>
      <td>Formally complain</td>
    </tr>
    <tr>
      <td>Reward</td>
    </tr>
    <tr>
      <td>Grant</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Promise policy support</td>
    </tr>
    <tr>
      <td>Offer peace proposal</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Surgery">Surgery</a></td>
      <td>Surgery is a medical or dental specialty that uses operative manual and instrumental techniques on a person to investigate or treat a pathological condition such as a disease or injury, to help improve bodily function, appearance, or to repair unwanted ruptured areas.\nThe act of performing surgery may be called a surgical procedure, operation, or simply "surgery".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bitwise_operation">Bitwise operation</a></td>
      <td>In computer programming, a bitwise operation operates on a bit string, a bit array or a binary numeral (considered as a bit string) at the level of its individual bits. It is a fast and simple action, basic to the higher-level arithmetic operations and directly supported by the processor.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Market_trend">Market trend</a></td>
      <td>A market trend is a perceived tendency of financial markets to move in a particular direction over time. These trends are classified as secular for long time frames, primary for medium time frames, and secondary for short time frames.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Market_power">Market power</a></td>
      <td>In economics, market power refers to the ability of a firm to influence the price at which it sells a product or service by manipulating either the supply or demand of the product or service to increase economic profit. In other words, market power occurs if a firm does not face a perfectly elastic demand curve and can set its price (P) above marginal cost (MC) without losing revenue.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Price_discrimination">Price discrimination</a></td>
      <td>Price discrimination is a microeconomic pricing strategy where identical or largely similar goods or services are sold at different prices by the same provider in different markets. Price discrimination is distinguished from product differentiation by the more substantial difference in production cost for the differently priced products involved in the latter strategy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Price_Chopper_and_Market_32_Supermarkets">Price Chopper and Market 32 Supermarkets</a></td>
      <td>Golub Corporation is an American supermarket operator. Headquartered in Schenectady, New York, it owns the chains Market 32 and Price Chopper Supermarkets.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Pricing">Pricing</a></td>
      <td>Pricing is the process whereby a business sets the price at which it will sell its products and services, and may be part of the business's marketing plan. In setting prices, the business will take into account the price at which it could acquire the goods, the manufacturing cost, the marketplace, competition, market condition, brand, and quality of product.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Volatility_(finance)">Volatility (finance)</a></td>
      <td>In finance, volatility (usually denoted by σ) is the degree of variation of a trading price series over time, usually measured by the standard deviation of logarithmic returns.\nHistoric volatility measures a time series of past market prices.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Non-price_competition">Non-price competition</a></td>
      <td>Non-price competition is a marketing strategy "in which one firm tries to distinguish its product or service from competing products on the basis of attributes like design and workmanship". It often occurs in imperfectly competitive markets because it exists between two or more producers that sell goods and services at the same prices but compete to increase their respective market shares through non-price measures such as marketing schemes and greater quality.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Market_structure">Market structure</a></td>
      <td>Market structure, in economics, depicts how firms are differentiated and categorised based on the types of goods they sell (homogeneous/heterogeneous) and how their operations are affected by external factors and elements. Market structure makes it easier to understand the characteristics of diverse markets.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/BIOVIA">BIOVIA</a></td>
      <td>BIOVIA is a software company headquartered in the United States, with representation in Europe and Asia. It provides software for chemical, materials and bioscience research for the pharmaceutical, biotechnology, consumer packaged goods, aerospace, energy and chemical industries.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Porter's_five_forces_analysis">Porter's five forces analysis</a></td>
      <td>Porter's Five Forces Framework is a method of analysing the operating environment of a competition of a business. It draws from industrial organization (IO) economics to derive five forces that determine the competitive intensity and, therefore, the attractiveness (or lack thereof) of an industry in terms of its profitability.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Technology">Technology</a></td>
      <td>Technology is the result of accumulated knowledge and application of skills, methods, and processes used in industrial production and scientific research. Technology is embedded in the operation of all machines, with or without detailed knowledge of their function, for the intended purpose of an organization.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profit_(economics)">Profit (economics)</a></td>
      <td>An economic profit is the difference between the revenue a  commercial entity has received from its outputs and the opportunity costs of its inputs. It equals to total revenue minus total cost, including both explicit and implicit costs.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profitability_analysis">Profitability analysis</a></td>
      <td>In cost accounting, profitability analysis is an analysis of the profitability of an organisation's output. Output of an organisation can be grouped into products, customers, locations, channels and/or transactions.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profitability_index">Profitability index</a></td>
      <td>Profitability index (PI), also known as profit investment ratio (PIR) and value investment ratio (VIR), is the ratio of payoff to investment of a proposed project. It is a useful tool for ranking projects because it allows you to quantify the amount of value created per unit of investment.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Customer_Profitability_Analysis">Customer Profitability Analysis</a></td>
      <td>Customer Profitability Analysis (in short CPA) is a management accounting and a credit underwriting method, allowing businesses and lenders to determine the profitability of each customer or segments of customers, by attributing profits and costs to each customer separately. CPA can be applied at the individual customer level (more time consuming, but providing a better understanding of business situation) or at the level of customer aggregates / groups (e.g.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Small_Is_Profitable">Small Is Profitable</a></td>
      <td>Small Is Profitable: The Hidden Economic Benefits of Making Electrical Resources the Right Size is a 2002 book by energy analyst Amory Lovins and others.  The book describes 207 ways in which the size of "electrical resources"—devices that make, save, or store electricity—affects their economic value.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profitable_growth">Profitable growth</a></td>
      <td>Profitable Growth is the combination of profitability and growth, more precisely the combination of Economic Profitability and Growth of Free cash flows. Profitable growth is aimed at seducing the financial community; it emerged in the early 80s when shareholder value creation became firms’ main objective.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Customer_profitability">Customer profitability</a></td>
      <td>Customer Profitability Analysis (in short CPA) is a management accounting and a credit underwriting method, allowing businesses and lenders to determine the profitability of each customer or segments of customers, by attributing profits and costs to each customer separately. CPA can be applied at the individual customer level (more time consuming, but providing a better understanding of business situation) or at the level of customer aggregates / groups (e.g.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/SAP_ERP">SAP ERP</a></td>
      <td>SAP ERP is an enterprise resource planning software developed by the German company SAP SE. SAP ERP incorporates the key business functions of an organization. The latest version of SAP ERP (V.6.0) was made available in 2006.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Net_income">Net income</a></td>
      <td>In business and accounting, net income (also total comprehensive income, net earnings, net profit, bottom line, sales profit, or credit sales) is an entity's income minus cost of goods sold, expenses, depreciation and amortization, interest, and taxes for an accounting period.It is computed as the residual of all revenues and gains less all expenses and losses for the period, and has also been defined as the net increase in shareholders' equity that results from a company's operations. It is different from gross income, which only deducts the cost of goods sold from revenue.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Faysal_Sohail">Faysal Sohail</a></td>
      <td>Faysal A. Sohail (born December 1963) is an American venture capitalist and Managing Director at Presidio Partners in San Francisco.  Sohail was a co-founder of Silicon Architects and on the founding team of Actel Corporation, two influential companies in the computer chip industry.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Peter_G._Schultz">Peter G. Schultz</a></td>
      <td>Peter G. Schultz (born June 23, 1956)  is an American chemist.  He is the CEO and Professor of Chemistry at The Scripps Research Institute, the founder and former director of GNF, and the founding director of the California Institute for Biomedical Research (Calibr), established in 2012.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Combinatorial_chemistry">Combinatorial chemistry</a></td>
      <td>Combinatorial chemistry comprises chemical synthetic methods that make it possible to prepare a large number (tens to thousands or even millions) of compounds in a single process. These compound libraries can be made as mixtures, sets of individual compounds or chemical structures generated by computer software.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/TRIPS_Agreement">TRIPS Agreement</a></td>
      <td>The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is an international legal agreement between all the member nations of the World Trade Organization (WTO). It establishes minimum standards for the regulation by national governments of different forms of intellectual property (IP) as applied to nationals of other WTO member nations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Intellectual_property_infringement">Intellectual property infringement</a></td>
      <td>An intellectual property (IP) infringement is the infringement or violation of an intellectual property right. There are several types of intellectual property rights, such as copyrights, patents, trademarks, industrial designs, and trade secrets.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Raytheon_Technologies">Raytheon Technologies</a></td>
      <td>Raytheon Technologies Corporation is an American multinational aerospace and defense conglomerate headquartered in Waltham, Massachusetts. It is one of the largest aerospace, intelligence services providers, and defense manufacturers in the world by revenue and market capitalization.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/HCL_Technologies">HCL Technologies</a></td>
      <td>HCL Technologies (Hindustan Computers Limited) is an Indian multinational information technology (IT) services and consulting company headquartered in Noida. It is a subsidiary of HCL Enterprise.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Palantir_Technologies">Palantir Technologies</a></td>
      <td>Palantir Technologies is a public American software company that specializes in big data analytics. Headquartered in Denver, Colorado, it was founded by Peter Thiel, Nathan Gettings, Joe Lonsdale, Stephen Cohen, and Alex Karp in 2003.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/United_Technologies">United Technologies</a></td>
      <td>United Technologies Corporation (UTC) was an American multinational conglomerate headquartered in Farmington, Connecticut.  It researched, developed, and manufactured products in numerous areas, including aircraft engines, aerospace systems, HVAC, elevators and escalators, fire and security, building automation, and industrial products, among others.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emerging_technologies">Emerging technologies</a></td>
      <td>Emerging technologies are technologies whose development, practical applications, or both are still largely unrealized, such that they are figuratively emerging into prominence from a background of nonexistence or obscurity. These technologies are generally new but also include older technologies.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/L3Harris_Technologies">L3Harris Technologies</a></td>
      <td>L3Harris Technologies (L3Harris) is an American technology company, defense contractor, and information technology services provider that produces C6ISR systems and products, wireless equipment, tactical radios, avionics and electronic systems, night vision equipment, and both terrestrial and spaceborne antennas for use in the government, defense, and commercial sectors. They specialize in surveillance solutions, microwave weaponry, and electronic warfare.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>SYMYX TECHNOLOGIES INC      Item 1A                Risk Factors       Set forth below and elsewhere in this <font color="blue">Annual Report </font>on Form 10 K and in     other <font color="blue">documents</font> we file with the SEC are risks and <font color="blue">uncertainties</font> that could     cause actual results to <font color="blue">differ <font color="blue">materially</font> from</font> the results contemplated by     the forward-looking statements contained in this <font color="blue">Annual Report </font>on Form 10 K     These are not the only risks and <font color="blue">uncertainties</font> facing us</td>
    </tr>
    <tr>
      <td><font color="blue">Additional </font>risks     and  <font color="blue">uncertainties</font> not <font color="blue">presently known</font> to us or that we currently deem     <font color="blue">immaterial also may impair</font> our business <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Most of our revenue is <font color="blue">generated from</font> a small number of key customers and     the loss of a <font color="blue">key customer could substantially reduce</font> our revenues and be     perceived as a loss of momentum in our business       Over time we have expanded our base of customers and <font color="blue"><font color="blue">collaborative</font> partners</font>,     however, substantial portions of our revenues are <font color="blue">generated from</font> a small     number of companies</td>
    </tr>
    <tr>
      <td>In particular, <font color="blue">ExxonMobil and The Dow Chemical Company     </font>accounted for 39prca and 25prca, respectively, of our <font color="blue">total revenue</font> in 2005</td>
    </tr>
    <tr>
      <td>We     expect that ExxonMobil, The Dow Chemical Company, and a select list of other     companies  will in the <font color="blue">aggregate continue</font> to account for a substantial     portion of our revenues for the <font color="blue">foreseeable future</font> and the loss of one or     more of these customers or <font color="blue"><font color="blue">collaborative</font> partners</font> would harm our business     and  operating  results</td>
    </tr>
    <tr>
      <td>The <font color="blue">cancellation</font> of the ExxonMobil or The Dow     Chemical Company <font color="blue">strategic alliance</font> or loss of another <font color="blue"><font color="blue">significant</font> customer</font>     or <font color="blue"><font color="blue">collaborative</font> partner could also</font> be perceived as a loss of momentum in     our business and have an <font color="blue">adverse impact on</font> our financial results, which may     cause the <font color="blue">market price</font> of our <font color="blue">common stock</font> to fall</td>
    </tr>
    <tr>
      <td>Failure to integrate our various software products and achieve customer     <font color="blue">acceptance</font> of the electronic laboratory notebook <font color="blue">technology</font> would harm our     revenue and operating results       We recently acquired IntelliChem, Inc</td>
    </tr>
    <tr>
      <td>and Synthematix, Inc, providers of     <font color="blue">electronic lab notebook software</font></td>
    </tr>
    <tr>
      <td>Our success is <font color="blue">partially <font color="blue"><font color="blue">dependent</font> on</font></font> our     ability  to  <font color="blue">successfully</font>  integrate the software we acquired in these     <font color="blue"><font color="blue">acquisition</font>s</font>  with  our <font color="blue">existing software</font> and with each other</td>
    </tr>
    <tr>
      <td>If this     <font color="blue">integration</font> is not successful or if the <font color="blue">integrated software products</font> do not     achieve substantial market <font color="blue">acceptance</font> among new and existing customers, due     to factors such as <font color="blue">technological</font> problems, <font color="blue">competition</font>, pricing, sales     execution or market shifts, it will have a material adverse effect on our     revenues and operating results</td>
    </tr>
    <tr>
      <td>Business <font color="blue"><font color="blue">activities</font> such as</font> the <font color="blue">development</font> of a new line of business or the     <font color="blue">acquisition</font> of a company or <font color="blue"><font color="blue">technology</font> could disrupt</font> our business, affect     our operating results and distract our <font color="blue"><font color="blue">management</font> team</font>       We have recently completed two <font color="blue"><font color="blue">acquisition</font>s</font>, and in the future, we may     engage in <font color="blue">additional</font> <font color="blue"><font color="blue">acquisition</font>s</font> and expand our business focus in order to     <font color="blue">exploit <font color="blue">technology</font></font> or <font color="blue">market opportunities</font></td>
    </tr>
    <tr>
      <td>In the event of any future     <font color="blue"><font color="blue">acquisition</font>s</font>,  we  may  issue  stock  that  would  dilute  our current     <font color="blue">stockholders</font>’  percentage  ownership, pay cash, incur debts, or assume     <font color="blue">liabilities</font></td>
    </tr>
    <tr>
      <td>We may not be able to <font color="blue">successfully</font> integrate our recently     acquired business, IntelliChem, Inc</td>
    </tr>
    <tr>
      <td>and Synthematix, Inc, or any future     acquired business, into our existing business in a timely and non-disruptive     manner  or  at all</td>
    </tr>
    <tr>
      <td>In addition, <font color="blue"><font color="blue">acquisition</font>s</font> may <font color="blue">adversely</font> affect our     operating results and could result in, among other things, large one-time     <font color="blue">charges <font color="blue">associated with</font></font> acquired in-process research and <font color="blue">development</font>, future     write-offs of goodwill that is deemed to be impaired, restructuring charges     related to <font color="blue">consolidation</font> of <font color="blue">operations</font>, <font color="blue">charges <font color="blue">associated with</font></font>       14     ______________________________________________________________________       unknown or unforeseen <font color="blue">liabilities</font> of acquired businesses, increased general     and <font color="blue">administrative expenses</font>, and the loss of <font color="blue">key employees</font></td>
    </tr>
    <tr>
      <td>In the event     that we develop a new line of business, our <font color="blue">management</font>’s attention may be     diverted from normal daily <font color="blue">operations</font> of the business</td>
    </tr>
    <tr>
      <td>Furthermore, an     <font color="blue">acquisition</font> or business expansion may not produce the revenues, earnings or     business synergies that we anticipate</td>
    </tr>
    <tr>
      <td>The time, <font color="blue">capital <font color="blue">management</font></font> and     other <font color="blue">resources spent on</font> an <font color="blue">acquisition</font> or business expansion that fails to     meet our <font color="blue"><font color="blue">expectations</font> could</font> cause our business and <font color="blue">financial condition</font> to be     <font color="blue">materially</font> and <font color="blue"><font color="blue">adversely</font> affected</font></td>
    </tr>
    <tr>
      <td>We may not be able to maintain and grow a profitable business       Our ability to maintain or increase our rate of <font color="blue">profitability</font> and grow our     business is <font color="blue"><font color="blue">dependent</font> on</font> our ability to:       ·       make <font color="blue">discoveries</font> that our customers choose to <font color="blue">commercialize</font> that     generate a substantial stream of royalties and other revenue;       ·       <font color="blue">extend current collaboration research</font> and <font color="blue">development</font> <font color="blue">arrangements</font>     and <font color="blue">add new ones</font>;       ·       <font color="blue">secure new</font> <font color="blue">Symyx Tools </font>customers; and       ·       <font color="blue"><font color="blue">add <font color="blue">additional</font></font> licensees</font> of both our software and <font color="blue">intellectual</font>     property</td>
    </tr>
    <tr>
      <td>Our  ability  to  achieve  our <font color="blue">objectives</font> and maintain or increase the     <font color="blue">profitability</font> of our business will depend in large part on <font color="blue">acceptance</font> by     potential  customers  of  our high-throughput screening <font color="blue">technology</font> and     <font color="blue">methodology</font>  as  an  <font color="blue">effective</font> tool in the <font color="blue">discovery</font> of <font color="blue">new materials</font></td>
    </tr>
    <tr>
      <td>Historically, <font color="blue">pharmaceutical</font> and <font color="blue">chemical companies</font> have <font color="blue">conducted materials</font>     research  and <font color="blue">discovery</font> <font color="blue">activities</font> internally using traditional manual     <font color="blue">discovery</font> methods</td>
    </tr>
    <tr>
      <td>In order for us to achieve our business <font color="blue">objectives</font>, we     <font color="blue">must convince</font> these companies that our <font color="blue">technology</font> and <font color="blue">capabilities justify</font>     outsourcing part of their <font color="blue">basic research</font> and <font color="blue">discovery</font> programs</td>
    </tr>
    <tr>
      <td>We cannot     assure you that we will achieve the levels of customer <font color="blue">acceptance</font> that will     be <font color="blue">necessary</font> for us to maintain and grow a profitable business</td>
    </tr>
    <tr>
      <td>A failure to     achieve the <font color="blue">necessary</font> customer <font color="blue">acceptance</font> and <font color="blue">extend current collaborations</font>     and <font color="blue">add new ones</font>, <font color="blue">secure new</font> <font color="blue">Symyx Tools </font>customers, and <font color="blue">add <font color="blue">additional</font></font>     licensees of our software and <font color="blue">intellectual</font> property would <font color="blue">adversely</font> affect     our revenue and <font color="blue">profitability</font> and may cause our stock price to decrease</td>
    </tr>
    <tr>
      <td>Failure to <font color="blue">successfully</font> <font color="blue">commercialize</font> our <font color="blue">discoveries</font> would reduce our     revenues and <font color="blue">profitability</font> and harm our business       For us to achieve and sustain a <font color="blue"><font color="blue">significant</font> level</font> of <font color="blue">profitability</font>, we must     <font color="blue">continuously</font> make <font color="blue">discoveries</font> with <font color="blue">significant</font> <font color="blue">commercial potential</font></td>
    </tr>
    <tr>
      <td>If  we  license  our  discovered  materials,  sensor  <font color="blue">technologies</font>, or     <font color="blue">methodologies</font> to other companies, we typically do not receive <font color="blue">royalties on</font>     sales of <font color="blue">products by</font> our <font color="blue">partners until</font> they have <font color="blue">commenced commercial sales</font>     of <font color="blue">products containing</font> our materials or produced using our methods</td>
    </tr>
    <tr>
      <td>The     <font color="blue">commercialization</font>  of <font color="blue">discovered materials</font> can be a long and expensive     process and we <font color="blue">cannot control</font> our partners’ <font color="blue">activities</font> in this regard</td>
    </tr>
    <tr>
      <td>The     failure of our partners to <font color="blue">commercialize</font> <font color="blue">development</font> candidates resulting     from our <font color="blue"><font color="blue">research efforts</font> would reduce</font> our <font color="blue">future revenue</font> and would harm our     business and operating results</td>
    </tr>
    <tr>
      <td>In addition, our <font color="blue">partners may delay</font> or     cancel  <font color="blue">commercialization</font> of <font color="blue">development</font> candidates which may harm our     business and operating results</td>
    </tr>
    <tr>
      <td>In order for us to <font color="blue">commercialize</font> <font color="blue">development</font> candidates ourselves, we would     need to develop, or obtain <font color="blue">through outsourcing <font color="blue">arrangements</font></font>, the <font color="blue">capability</font>     to <font color="blue">manufacture</font>, market, and <font color="blue">sell products</font></td>
    </tr>
    <tr>
      <td>We do not have this <font color="blue">capability</font>,     and  we  may  not be able to develop or otherwise obtain the requisite     <font color="blue">manufacturing</font>,  marketing, and <font color="blue">sales capabilities</font></td>
    </tr>
    <tr>
      <td>If we are unable to     <font color="blue">successfully</font> <font color="blue">commercialize</font> products resulting from our <font color="blue"><font color="blue">proprietary</font> research</font>     efforts, our revenues and operating results <font color="blue">would decline</font></td>
    </tr>
    <tr>
      <td>15     ______________________________________________________________________       We are <font color="blue"><font color="blue">dependent</font> on</font> the research and <font color="blue">development</font> <font color="blue">activities</font> of companies in     the chemical, energy, <font color="blue">pharmaceutical</font>, electronics, consumer goods, and     automotive  <font color="blue">industries</font>,  and  declines  or  <font color="blue">reductions</font> in research and     <font color="blue">development</font> <font color="blue">activities</font> in these <font color="blue">industries</font> <font color="blue">could harm</font> our business       The market for our <font color="blue">discovery</font> services, <font color="blue">instrumentation</font>, and <font color="blue">software within</font>     the chemical, energy, <font color="blue">pharmaceutical</font>, electronics, consumer goods, and     automotive <font color="blue">industries</font> depends on our customers’ ability and <font color="blue">willingness</font> to     invest  in  research  and  <font color="blue">development</font></td>
    </tr>
    <tr>
      <td>A majority of our revenues are     <font color="blue">attributable</font>   to   our   <font color="blue">collaborative</font>  <font color="blue">arrangements</font>  with  chemical,     <font color="blue">pharmaceutical</font>, electronics, consumer goods, and <font color="blue">automotive companies</font></td>
    </tr>
    <tr>
      <td><font color="blue">These     </font><font color="blue">contracts generally</font> expire after a fixed period of time</td>
    </tr>
    <tr>
      <td>If we <font color="blue">cannot renew</font>     existing  contracts  or enter into new <font color="blue">collaborative</font> <font color="blue">arrangements</font>, our     business and operating results may be harmed</td>
    </tr>
    <tr>
      <td>In particular, many companies in the chemical and <font color="blue">pharmaceutical</font> <font color="blue">industries</font>     have, in the <font color="blue">past several years</font>, experienced declining <font color="blue">profitability</font> or even     losses</td>
    </tr>
    <tr>
      <td>As a result, some chemical and <font color="blue">pharmaceutical</font> companies have reduced     their  research and <font color="blue">development</font> <font color="blue">activities</font></td>
    </tr>
    <tr>
      <td>In addition, many chemical     products have become commodity products that <font color="blue">compete primarily on</font> the basis     of  price</td>
    </tr>
    <tr>
      <td>If <font color="blue">commoditization</font> of <font color="blue">chemical products</font> and other pressures     <font color="blue">affecting</font> the industry, including <font color="blue"><font color="blue">government</font>al</font> <font color="blue">regulations</font> and <font color="blue"><font color="blue">government</font>al</font>     spending, continue in the future, more <font color="blue">companies could adopt strategies</font> that     involve <font color="blue">significant</font> <font color="blue">reductions</font> in their research and <font color="blue">development</font> programs</td>
    </tr>
    <tr>
      <td><font color="blue">Although  </font>we  believe  that  our  approach  can help chemical, energy,     <font color="blue">pharmaceutical</font>,  electronics, consumer goods, and <font color="blue">automotive companies</font>     increase the <font color="blue">efficiency</font> of their research and <font color="blue">development</font> <font color="blue">activities</font>, our     efforts to <font color="blue">convince them</font> of this value may be <font color="blue">unsuccessful</font></td>
    </tr>
    <tr>
      <td>To the extent     that these companies reduce their research and <font color="blue">development</font> <font color="blue">activities</font>, they     would be less likely to do business with us</td>
    </tr>
    <tr>
      <td>As a result of current negative     economic <font color="blue">conditions</font>, a number of these companies have recently both reduced     the size of their research and <font color="blue">development</font> budgets as well as the size of     their workforces</td>
    </tr>
    <tr>
      <td><font color="blue">Decisions </font>by these companies to reduce their research and     <font color="blue">development</font> <font color="blue">activities</font> could result in fewer or <font color="blue">smaller scale collaborations</font>     with us, fewer or smaller scale <font color="blue">intellectual</font> property and <font color="blue">software licenses</font>,     <font color="blue">fewer sales</font> of our <font color="blue">Symyx Tools </font>systems and related licenses and products, or     choosing not to work with Symyx, any of <font color="blue"><font color="blue">which could</font> reduce</font> our revenues and     harm our business and operating results</td>
    </tr>
    <tr>
      <td>We  cannot  predict  the pace, quality or number of <font color="blue">discoveries</font> we may     generate, and any <font color="blue">inability</font> of ours to generate a <font color="blue">significant</font> number of     <font color="blue">discoveries</font> would reduce our revenues and harm our business       Our <font color="blue">future revenue</font>s and <font color="blue">profitability</font> are <font color="blue"><font color="blue">dependent</font> upon</font> our ability to     achieve  <font color="blue">discoveries</font>, whether through collaborations with customers or     through our own <font color="blue"><font color="blue">proprietary</font> research</font>, which our partners or we choose to     <font color="blue">commercialize</font></td>
    </tr>
    <tr>
      <td>Because of the <font color="blue">inherently uncertain</font> nature of research     <font color="blue">activities</font>, we <font color="blue">cannot predict with</font> a <font color="blue">high level</font> of precision the pace with     which we may generate <font color="blue">discoveries</font> or the quality of any <font color="blue">discoveries</font> that we     may generate</td>
    </tr>
    <tr>
      <td>Due to the uncertain nature of materials <font color="blue">discovery</font>, in which     <font color="blue">several hundred thousand compounds must often</font> be screened to identify a     single <font color="blue">development</font> candidate, we may not generate the number of <font color="blue">discoveries</font>     that we would expect to <font color="blue">generate from</font> a given number of <font color="blue">experiments</font>, or any     <font color="blue">discoveries</font> at all</td>
    </tr>
    <tr>
      <td>In addition, our <font color="blue">development</font> candidates may not result     in  products  having  the <font color="blue">commercial potential</font> our <font color="blue"><font color="blue">collaborator</font>s</font> or we     anticipate</td>
    </tr>
    <tr>
      <td>If this happens, our existing and <font color="blue">potential new customers may</font>     not renew or <font color="blue">enter into new <font color="blue">agreements</font> with us</font></td>
    </tr>
    <tr>
      <td>Consequently, our future     <font color="blue">revenues from</font> our <font color="blue">research collaborations</font> and from <font color="blue">commercialization</font> of our     discovered  materials  would  <font color="blue">likely decline</font> and harm our business and     operating results</td>
    </tr>
    <tr>
      <td><font color="blue">Difficulties </font>we <font color="blue"><font color="blue">may encounter</font> managing</font> our growth may divert resources and     limit our ability to <font color="blue">successfully</font> expand our <font color="blue">operations</font>       We  have experienced a period of rapid and substantial growth that has     placed, and our anticipated growth in the <font color="blue">future will continue</font> to place, a     strain on our research, administrative, and <font color="blue">operational <font color="blue">infrastructure</font></font></td>
    </tr>
    <tr>
      <td>As     our <font color="blue">operations</font> expand domestically and <font color="blue"><font color="blue">international</font>ly</font>, we will need to     continue to <font color="blue">manage multiple locations</font> and <font color="blue"><font color="blue">additional</font> <font color="blue">relationship</font>s with</font>     various <font color="blue"><font color="blue">collaborative</font> partners</font>, suppliers, and       16     ______________________________________________________________________       other  third  parties</td>
    </tr>
    <tr>
      <td>Our ability to manage our <font color="blue">operations</font> and growth     <font color="blue">effective</font>ly requires us to continue to improve our reporting systems and     <font color="blue">procedures as well as</font> our operational, financial and <font color="blue"><font color="blue">management</font> controls</font></td>
    </tr>
    <tr>
      <td>In     addition, recent SEC rules and <font color="blue">regulations</font> have increased the internal     control and <font color="blue"><font color="blue">regulatory</font> <font color="blue">requirements</font> under which</font> we operate</td>
    </tr>
    <tr>
      <td>We may not be     able to <font color="blue">successfully</font> improve our <font color="blue">management</font> information and <font color="blue">control systems</font>     to a level <font color="blue">necessary</font> to manage our growth and we <font color="blue">may discover <font color="blue">deficiencies</font></font>     in <font color="blue">existing systems</font> and controls that we may not be able to remediate in an     <font color="blue">efficient</font> or <font color="blue">timely manner</font></td>
    </tr>
    <tr>
      <td>We  conduct  <font color="blue">research programs</font> for our own account and for a number of     <font color="blue"><font color="blue">collaborative</font> partners</font>, and any <font color="blue">conflicts between</font> these <font color="blue">programs would harm</font>     our business       Our strategy includes conducting <font color="blue">research programs</font> for our own <font color="blue">account as</font>     well  as for <font color="blue"><font color="blue">collaborative</font> partners</font></td>
    </tr>
    <tr>
      <td>We believe that our <font color="blue">collaborative</font>     <font color="blue">agreements</font> are structured in a manner to <font color="blue">enable us</font> to <font color="blue">minimize conflicts</font>     with our <font color="blue"><font color="blue">collaborator</font>s</font> relating to rights to <font color="blue"><font color="blue">potentially</font> overlapping leads</font>     developed <font color="blue">through programs</font> for our own account and <font color="blue">through programs</font> funded     by a <font color="blue">collaborator</font>, or <font color="blue">through programs</font> funded by different <font color="blue"><font color="blue">collaborator</font>s</font></td>
    </tr>
    <tr>
      <td>However, <font color="blue">conflicts between</font> a <font color="blue">collaborator</font> and us, or between <font color="blue"><font color="blue">collaborator</font>s</font>,     <font color="blue">could <font color="blue">potentially</font></font> arise</td>
    </tr>
    <tr>
      <td>In this event, we <font color="blue">may <font color="blue">become involved</font></font> in a dispute     with our <font color="blue"><font color="blue">collaborator</font>s</font> regarding the material</td>
    </tr>
    <tr>
      <td>Disputes of this nature could     harm  the  <font color="blue">relationship</font> between us and our <font color="blue"><font color="blue">collaborator</font>s</font>, and concerns     regarding our <font color="blue"><font color="blue">proprietary</font> research</font> programs could also affect our ability to     enter  into new <font color="blue">collaborative</font> <font color="blue">relationship</font>s and cause our revenues and     operating results to decline</td>
    </tr>
    <tr>
      <td>We have a limited number of contracts for the sale of <font color="blue">Symyx Tools </font>systems     and for the licensing of <font color="blue">intellectual</font> property, software, <font color="blue">technologies</font>, and     materials to date, and we <font color="blue">cannot assure</font> you that we will be able to build a     sustainable business related to either the sale of <font color="blue"><font color="blue">additional</font> systems</font> or the     licensing of <font color="blue">intellectual</font> property, software, <font color="blue">technologies</font>, and materials       To date, we have entered a <font color="blue">growing but still</font> limited number of contracts for     our <font color="blue">Symyx Tools </font>systems</td>
    </tr>
    <tr>
      <td>Because of the high cost and <font color="blue">complexity</font> of these     systems, the <font color="blue">sales cycle</font> for them has been and is likely to continue to be     long</td>
    </tr>
    <tr>
      <td>Sales of these systems will require us to educate our potential     customers  about the full benefits of these systems, which may require     <font color="blue">significant</font> time</td>
    </tr>
    <tr>
      <td>Sales  of  <font color="blue">Symyx Tools </font>systems and licensing of <font color="blue">intellectual</font> property,     software,  <font color="blue">technologies</font>,  and <font color="blue">materials will</font> be subject to a number of     <font color="blue">significant</font> risks over which we have little or no control, including:       ·       customers’ budgetary constraints and internal <font color="blue">acceptance</font> review     procedures;       ·       customers’ <font color="blue">willingness</font> to <font color="blue">acknowledge</font> the validity of our patent     portfolio and their need to obtain a license to our <font color="blue">intellectual</font> property in     order to undertake research using high-throughput combinatorial <font color="blue">chemistry</font>     methods;       ·       <font color="blue">complexity</font> of our systems and <font color="blue"><font color="blue">difficult</font>ies</font> we <font color="blue">may encounter</font> in     meeting individual <font color="blue">customer specifications</font> and <font color="blue">commitments on</font> a timely     basis;       ·       our ability to <font color="blue">build new systems</font> and <font color="blue">design software</font> and workflows     to meet the demands of our customers;       ·        customers’  <font color="blue">willingness</font> to <font color="blue">renew annual</font> right to use software     licenses;       ·       the fact that there may be only a limited number of customers that     are  willing  to  purchase  our <font color="blue">larger systems</font> or <font color="blue">enter into licensing</font>     <font color="blue">agreements</font> with us;       ·       a long <font color="blue">sales cycle</font> that involves substantial human and capital     resources; and       ·       <font color="blue">potential downturns</font> in general or in <font color="blue">industry specific economic</font>     <font color="blue">conditions</font></td>
    </tr>
    <tr>
      <td>17     ______________________________________________________________________       If we are unable to continue to build the <font color="blue">infrastructure</font> to support Symyx     Tools and <font color="blue">intellectual</font> property and software licensing, or if the sales or     build cycles for <font color="blue">Symyx Tools </font><font color="blue">systems lengthen unexpectedly</font>, our <font color="blue">revenues may</font>     decline or not grow as anticipated and our results from <font color="blue">operations</font> may be     harmed</td>
    </tr>
    <tr>
      <td>The loss of <font color="blue">key personnel</font> or the <font color="blue">inability</font> to attract and retain <font color="blue">additional</font>     <font color="blue">personnel could</font> have a material adverse effect on our results of <font color="blue">operations</font>       We believe our <font color="blue">future success will depend upon</font> our ability to attract and     retain <font color="blue">highly skilled personnel</font>, including <font color="blue">key scientific</font> and managerial     personnel</td>
    </tr>
    <tr>
      <td>As we seek to expand our <font color="blue">operations</font>, the hiring of qualified     scientific and <font color="blue"><font color="blue">technical personnel</font> will</font> be <font color="blue">difficult</font>, as the number of     people with experience in high-throughput materials science is limited and     we <font color="blue">may face <font color="blue">competition</font></font> for qualified professionals, especially in the San     Francisco Bay Area, where we are <font color="blue">headquartered</font></td>
    </tr>
    <tr>
      <td>Further, as we form new     <font color="blue">alliances with</font> other <font color="blue">collaboration partners</font>, we may need <font color="blue">personnel with</font>     <font color="blue">specific skill sets</font> that may be <font color="blue">difficult</font> to locate or attract</td>
    </tr>
    <tr>
      <td>Failure to     attract  and  retain  personnel, <font color="blue">particularly</font> scientific and technical     personnel, would impair our ability to grow our business and pursue new     <font color="blue">discovery</font> <font color="blue">initiatives</font> and <font color="blue">collaborative</font> <font color="blue">arrangements</font></td>
    </tr>
    <tr>
      <td><font color="blue">Competition </font><font color="blue">could increase</font>, and <font color="blue">competitive</font> <font color="blue">development</font>s could render our     <font color="blue">technologies</font> obsolete or <font color="blue">non<font color="blue">competitive</font></font>, which would reduce our revenues and     harm our business       The field of high-throughput materials science is <font color="blue">increasingly <font color="blue">competitive</font></font></td>
    </tr>
    <tr>
      <td>We are aware of companies that may apply their expertise in high-throughput     <font color="blue">chemistry</font> to their <font color="blue">internal materials research</font> and <font color="blue">development</font> programs</td>
    </tr>
    <tr>
      <td>In     addition,  there  are <font color="blue">companies focusing on aspects</font> of high-throughput     <font color="blue">chemistry</font> for the <font color="blue">discovery</font> of materials</td>
    </tr>
    <tr>
      <td>In addition, academic and research     <font color="blue">institutions may seek</font> to develop <font color="blue">technologies</font> that would be <font color="blue"><font color="blue">competitive</font> with</font>     our <font color="blue">technologies</font> for materials <font color="blue">discovery</font></td>
    </tr>
    <tr>
      <td>Because high-throughput materials     science is an emerging field, <font color="blue">competition</font> from <font color="blue">additional</font> entrants may     increase</td>
    </tr>
    <tr>
      <td>Our <font color="blue">Symyx Tools </font>and Symyx Software business groups are facing     increasing  <font color="blue">competition</font>  from a number of instrument <font color="blue">manufacturing</font> and     software  companies</td>
    </tr>
    <tr>
      <td>To  the extent these companies develop competing     <font color="blue">technologies</font>, our own <font color="blue">technologies</font>, <font color="blue">methodologies</font>, systems and workflows,     and software could be rendered obsolete or <font color="blue">non<font color="blue">competitive</font></font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">inability</font> to <font color="blue"><font color="blue">adequately</font> protect</font> our <font color="blue">proprietary</font> <font color="blue">technologies</font> <font color="blue">could harm</font>     our <font color="blue"><font color="blue">competitive</font> position</font> and have a material adverse effect on our business       The success of our business depends, in part, on our ability to obtain     patents and maintain <font color="blue">adequate protection</font> of our <font color="blue">intellectual</font> property for     our <font color="blue">technologies</font> and products in the US and other countries</td>
    </tr>
    <tr>
      <td>The laws of     some foreign countries do not protect <font color="blue">proprietary</font> rights to the <font color="blue">same extent</font>     as the laws of the US, and many companies have <font color="blue">encountered</font> <font color="blue">significant</font>     problems in protecting their <font color="blue">proprietary</font> rights in these foreign countries</td>
    </tr>
    <tr>
      <td>If we do     not <font color="blue"><font color="blue">adequately</font> protect</font> our <font color="blue">intellectual</font> property, <font color="blue">competitors</font> may be able to     practice our <font color="blue">technologies</font> and erode our <font color="blue"><font color="blue">competitive</font> advantage</font>, and our     business and operating results could be harmed</td>
    </tr>
    <tr>
      <td>The  patent  positions  of  <font color="blue">technology</font> companies, including our patent     positions,  are  <font color="blue">often uncertain</font> and <font color="blue">involve complex legal</font> and factual     questions</td>
    </tr>
    <tr>
      <td>We  will  be  able  to protect our <font color="blue">proprietary</font> rights from     <font color="blue">unauthorized use by <font color="blue">third parties</font> only</font> to the extent that our <font color="blue">proprietary</font>     <font color="blue">technologies</font> are <font color="blue">covered by valid</font> and <font color="blue">enforceable patents</font> or are <font color="blue">effective</font>ly     maintained <font color="blue">as <font color="blue">trade secrets</font></font></td>
    </tr>
    <tr>
      <td>We apply for <font color="blue">patents covering</font> our <font color="blue">technologies</font>     and <font color="blue">products as</font> we deem <font color="blue">appropriate</font></td>
    </tr>
    <tr>
      <td>However, we may not obtain patents on     all <font color="blue">inventions</font> for which we <font color="blue">seek patents</font>, and any patents we obtain may be     challenged and may be narrowed in scope or <font color="blue">extinguished as</font> a result of such     <font color="blue">challenges</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">existing patents</font> and any <font color="blue">future patents</font> we obtain may not       18     ______________________________________________________________________       be <font color="blue">sufficiently broad</font> to <font color="blue">prevent others from practicing</font> our <font color="blue">technologies</font> or     from developing <font color="blue">competing products</font></td>
    </tr>
    <tr>
      <td>Others <font color="blue">may in<font color="blue">dependent</font>ly</font> develop similar     or <font color="blue">alternative</font> <font color="blue">technologies</font> or <font color="blue">design around</font> our patented <font color="blue">technologies</font> or     products</td>
    </tr>
    <tr>
      <td>These <font color="blue">companies would then</font> be able to <font color="blue">offer <font color="blue">research services</font></font> and     develop,  <font color="blue">manufacture</font> and <font color="blue">sell products</font> that <font color="blue">compete directly with</font> our     <font color="blue">research services</font> and products</td>
    </tr>
    <tr>
      <td>In that case, our revenues and operating     results <font color="blue">would decline</font></td>
    </tr>
    <tr>
      <td>We  rely  <font color="blue">upon trade secret protection</font> for certain of our <font color="blue">confidential</font>     information</td>
    </tr>
    <tr>
      <td>We have <font color="blue">taken measures</font> to protect our <font color="blue">confidential</font> information</td>
    </tr>
    <tr>
      <td>These <font color="blue">measures may</font> not provide <font color="blue">adequate protection</font> for our <font color="blue">trade secrets</font> or     other  <font color="blue">confidential</font>  information</td>
    </tr>
    <tr>
      <td>We seek to protect our <font color="blue">confidential</font>     information by entering into <font color="blue">confidential</font>ity <font color="blue">agreements</font> with employees,     <font color="blue"><font color="blue">collaborator</font>s</font>, and <font color="blue">consultants</font></td>
    </tr>
    <tr>
      <td>Nevertheless, employees, <font color="blue"><font color="blue">collaborator</font>s</font> or     <font color="blue">consultants</font> may still disclose or misuse our <font color="blue">confidential</font> information, and     we may not be able to <font color="blue">meaningfully protect</font> our <font color="blue">trade secrets</font></td>
    </tr>
    <tr>
      <td>In addition,     others <font color="blue">may in<font color="blue">dependent</font>ly</font> develop <font color="blue">substantially equivalent</font> information or     <font color="blue">techniques</font> or <font color="blue">otherwise gain access</font> to our <font color="blue">trade secrets</font></td>
    </tr>
    <tr>
      <td><font color="blue">Disclosure </font>or     misuse of our <font color="blue">confidential</font> information would harm our <font color="blue"><font color="blue">competitive</font> position</font>     and could cause our revenues and operating results to decline</td>
    </tr>
    <tr>
      <td>Failure to <font color="blue">adequately</font> enforce our <font color="blue">intellectual</font> <font color="blue">property rights</font> <font color="blue">could harm</font>     our <font color="blue"><font color="blue">competitive</font> position</font> and have a material adverse effect on our business       Our <font color="blue"><font color="blue">success depends</font> on</font> our ability to enforce our <font color="blue">intellectual</font> property     <font color="blue">rights through either <font color="blue">litigation</font></font> or licensing</td>
    </tr>
    <tr>
      <td>To be successful in enforcing     our <font color="blue">intellectual</font> property through <font color="blue">litigation</font> or <font color="blue">licensing there</font> are several     aspects to consider, including maintaining the validity of our <font color="blue">intellectual</font>     property, proving that others are infringing and obtaining a <font color="blue">commercially</font>     <font color="blue">significant</font> outcome as a result of <font color="blue">such infringement</font></td>
    </tr>
    <tr>
      <td><font color="blue">Intellectual </font>property     <font color="blue">litigation</font> can be successful if our <font color="blue">intellectual</font> property withstands close     scrutiny</td>
    </tr>
    <tr>
      <td>If it does not withstand this scrutiny, we can lose part or all of     our <font color="blue">intellectual</font> property position</td>
    </tr>
    <tr>
      <td>If we lose part or all of our <font color="blue">intellectual</font> property position, whether     through <font color="blue">litigation</font> or <font color="blue">opposition <font color="blue">proceedings</font></font>, our business and operating     results may be harmed</td>
    </tr>
    <tr>
      <td>With  regard to <font color="blue">proving infringement</font> of our <font color="blue">intellectual</font> property, our     <font color="blue">success depends</font> in part on obtaining <font color="blue">useable knowledge</font> of what <font color="blue">technologies</font>     others are practicing</td>
    </tr>
    <tr>
      <td>If others do not publish or disclose the <font color="blue">technologies</font>     that they are using, our ability to <font color="blue">discover infringing uses</font> and enforce our     <font color="blue">intellectual</font> <font color="blue">property rights</font> will diminish</td>
    </tr>
    <tr>
      <td>If we are unable to enforce our     <font color="blue">intellectual</font>  <font color="blue">property rights</font> or if the ability to <font color="blue">enforce such rights</font>     <font color="blue">diminishes</font>,  our <font color="blue">revenues from</font> <font color="blue">intellectual</font> property licensing and our     operating results may decline</td>
    </tr>
    <tr>
      <td>Our <font color="blue">intellectual</font> property must protect our overall business <font color="blue">structure by</font>     <font color="blue">allowing us</font> to obtain <font color="blue">commercially</font> <font color="blue">significant</font> results from <font color="blue">litigation</font>,     including <font color="blue">compensation</font> and/or relevant injunctions, without resulting in     <font color="blue">undue cost</font> and expense</td>
    </tr>
    <tr>
      <td><font color="blue">Enforcement </font>of our <font color="blue">intellectual</font> property through     <font color="blue">litigation</font> can result in <font color="blue">significant</font> expenses, <font color="blue">distractions</font> and risks that     might cause us to lose focus or may otherwise harm our <font color="blue">profitability</font> and     weaken our <font color="blue">intellectual</font> property position</td>
    </tr>
    <tr>
      <td><font color="blue">Enforcement </font><font color="blue">proceedings</font> can     <font color="blue">adversely</font>  affect  our <font color="blue">intellectual</font> property while causing us to spend     <font color="blue">resources on</font> the enforcement <font color="blue">proceedings</font></td>
    </tr>
    <tr>
      <td>As our licensing <font color="blue">activities</font> have     matured, we have <font color="blue">become involved</font> in <font color="blue">arbitration</font> and <font color="blue">litigation</font> to assert and     defend our <font color="blue">intellectual</font> property</td>
    </tr>
    <tr>
      <td>These <font color="blue">matters may become</font> material and more     <font color="blue">such matters may</font> arise</td>
    </tr>
    <tr>
      <td><font color="blue">Successful </font><font color="blue">conclusion</font> of these <font color="blue">matters will assist</font>     our business, while <font color="blue">unsuccessful</font> <font color="blue">conclusion</font> of these <font color="blue">matters will cost us</font>     time and money and <font color="blue">possibly loss</font> of rights</td>
    </tr>
    <tr>
      <td>Our ability to manage the costs     of these <font color="blue">proceedings</font> to obtain a successful result cannot be predicted</td>
    </tr>
    <tr>
      <td>19     ______________________________________________________________________       Our business may be harmed if we are found to infringe <font color="blue">proprietary</font> rights of     others       Our <font color="blue">commercial success also depends</font> in part on ensuring we do not infringe     patents or other <font color="blue">proprietary</font> rights of <font color="blue">third parties</font></td>
    </tr>
    <tr>
      <td>Others have filed, and     in the future are likely to file, <font color="blue">patent applications</font> covering <font color="blue">technologies</font>     that we may wish to <font color="blue">utilize with</font> our <font color="blue">proprietary</font> <font color="blue">technologies</font>, or products     that are similar to products developed with the use of our <font color="blue">technologies</font></td>
    </tr>
    <tr>
      <td>If     these <font color="blue">patent applications</font> result in <font color="blue">issued patents</font> and we wish to use the     claimed <font color="blue">technology</font>, we would need to obtain a <font color="blue">license from</font> the <font color="blue">third party</font>     and this <font color="blue">would increase</font> our costs of <font color="blue">operations</font> and harm our operating     results</td>
    </tr>
    <tr>
      <td>Third <font color="blue">parties may</font> assert that we are employing their <font color="blue">proprietary</font> <font color="blue">technology</font>     <font color="blue">without authorization</font></td>
    </tr>
    <tr>
      <td>In addition, <font color="blue">third parties</font> may obtain patents in the     future and claim that use of our <font color="blue">technologies</font> infringes these patents</td>
    </tr>
    <tr>
      <td>We     <font color="blue">could incur</font> substantial costs and diversion of the time and attention of     <font color="blue">management</font> and <font color="blue">technical personnel</font> in <font color="blue">defending ourselves against</font> any such     claims</td>
    </tr>
    <tr>
      <td>Furthermore, parties making claims <font color="blue">against us may</font> be able to obtain     injunctive  or other <font color="blue">equitable relief</font> that could <font color="blue">effective</font>ly block our     ability to further develop, <font color="blue">commercialize</font>, and <font color="blue">sell products</font>, and such     claims could result in the award of substantial <font color="blue">damages against us</font></td>
    </tr>
    <tr>
      <td>In the     event of a successful claim of <font color="blue">infringement against us</font>, we may be required     to pay damages and obtain one or more licenses from <font color="blue">third parties</font></td>
    </tr>
    <tr>
      <td>We may     not be able to obtain these <font color="blue">licenses at</font> a <font color="blue">reasonable cost</font>, if at all</td>
    </tr>
    <tr>
      <td>In     that event, we <font color="blue">could encounter delays</font> in <font color="blue">product introductions while</font> we     attempt to develop <font color="blue"><font color="blue">alternative</font> methods</font> or products, or be required to cease     commercializing affected products, which would harm our operating results</td>
    </tr>
    <tr>
      <td>We expect that our quarterly results of <font color="blue">operations</font> will fluctuate, and this     <font color="blue">fluctuation could</font> cause our stock price to decline, causing <font color="blue">investor losses</font>       Our quarterly operating results have fluctuated in the past and are likely     to do so in the future</td>
    </tr>
    <tr>
      <td>These <font color="blue"><font color="blue">fluctuations</font> could</font> cause our stock price to     fluctuate <font color="blue">significant</font>ly or decline</td>
    </tr>
    <tr>
      <td>Revenues in future fiscal periods may be     greater or less than revenues in the <font color="blue">immediately preceding period</font> or in the     <font color="blue">comparable period</font> of the prior year</td>
    </tr>
    <tr>
      <td>Some of the factors that could cause     our operating results to fluctuate include:       ·       expiration of research contracts with major <font color="blue"><font color="blue">collaborative</font> partners</font>,     which may not be renewed or <font color="blue">replaced with contracts with</font> other companies;       ·       the <font color="blue">success rate</font> of our <font color="blue">discovery</font> efforts <font color="blue">associated with</font> milestones     and royalties;       ·        the  timing  and <font color="blue">willingness</font> of partners to <font color="blue">commercialize</font> our     <font color="blue">discoveries</font> that would result in royalties;       ·       <font color="blue">development</font>s or <font color="blue">disputes concerning patent</font> or other <font color="blue">proprietary</font>     rights;       ·       <font color="blue">special charges</font> related to <font color="blue"><font color="blue">acquisition</font>s</font>;       ·        the  size and timing of <font color="blue">customer orders</font> for shipments of, and     payments related to, <font color="blue">Symyx Tools </font><font color="blue">instrumentation</font>;       ·       the size and timing of royalties we receive from <font color="blue">third parties</font>,     including those who license our <font color="blue">laboratory <font color="blue">instruments</font></font> and software for     resale;       ·       the size and timing of <font color="blue">internal research</font> and <font color="blue">development</font> programs we     undertake on an un-funded basis;       ·       the size and timing of <font color="blue">both software</font> and <font color="blue">intellectual</font> property     licensing <font color="blue">agreements</font> we <font color="blue">may enter into</font>;       ·       changes in estimates and <font color="blue">underlying assumptions</font> related to our     warranty  expense accrual, inventory valuation reserve, and <font color="blue">income tax</font>     <font color="blue">valuation allowance</font>;       20     ______________________________________________________________________       ·       <font color="blue">inaccurate assessment</font> of demand for our products and services,     including our software;       ·       <font color="blue">fluctuations</font> in the <font color="blue">market values</font> of our <font color="blue">cash <font color="blue">equivalents</font></font> and short     and long-term <font color="blue"><font color="blue">investment</font>s</font> and in <font color="blue">interest rates</font>, including any gains or     losses arising on the sale of these <font color="blue"><font color="blue">investment</font>s</font>;       ·       changes in <font color="blue">accounting</font> rules and <font color="blue">regulations</font>, including those related     to  revenue  <font color="blue">recognition</font>  and  <font color="blue">accounting</font> for <font color="blue">stock options granted</font> to     employees; and       ·       general and <font color="blue">industry specific economic</font> <font color="blue">conditions</font>, which may affect     our  customers’ capital <font color="blue">investment</font> levels and research and <font color="blue">development</font>     <font color="blue"><font color="blue">investment</font> <font color="blue">decisions</font></font></td>
    </tr>
    <tr>
      <td>A  large  portion  of our expenses, including expenses for <font color="blue">facilities</font>,     equipment, and personnel, are <font color="blue">relatively</font> fixed in nature</td>
    </tr>
    <tr>
      <td>Accordingly, in     the event revenues decline or do not grow as anticipated due to expiration     of research contracts, failure to obtain new contracts or other factors, we     may not be able to <font color="blue">correspondingly reduce</font> our operating expenses</td>
    </tr>
    <tr>
      <td>Failure to     achieve anticipated levels of revenues could therefore <font color="blue">significant</font>ly harm     our operating results</td>
    </tr>
    <tr>
      <td>Due to the <font color="blue">possibility</font> of <font color="blue">fluctuations</font> in our revenues and expenses, we     believe that quarter-to-quarter comparisons of our operating results are not     a  good  <font color="blue">indication</font>  of  our  <font color="blue">future performance</font></td>
    </tr>
    <tr>
      <td>As a result of these     possible <font color="blue">fluctuations</font>, it is <font color="blue">difficult</font> for our <font color="blue">management</font> to predict or     estimate our quarterly or annual operating results and to give accurate     guidance</td>
    </tr>
    <tr>
      <td>Our  operating  results  in  some <font color="blue">quarters may</font> not meet the     <font color="blue">expectations</font> of <font color="blue">stock market analysts</font> and investors</td>
    </tr>
    <tr>
      <td>In that case, our stock     <font color="blue">price would probably decline</font>, and <font color="blue">investors would</font> experience a decline in     the value of their <font color="blue">investment</font></td>
    </tr>
    <tr>
      <td>Our stock price has been and <font color="blue">may continue</font> to be volatile       The <font color="blue">market price</font> of our <font color="blue">common stock</font> since our <font color="blue">initial public offering</font> has     <font color="blue">been highly volatile</font></td>
    </tr>
    <tr>
      <td><font color="blue">Volatility </font>in the <font color="blue">market price</font> for our <font color="blue">common stock</font>     will be <font color="blue">affected by</font> a number of factors, including the following:       ·       <font color="blue">decisions</font> by <font color="blue">significant</font> <font color="blue">stockholders</font> to acquire or divest their     stock holdings, given the <font color="blue">relatively</font> low average daily trading volumes we     have <font color="blue">historically</font> experienced;       ·        the  <font color="blue">announcement</font>  of  new  products or <font color="blue">services by us</font> or our     <font color="blue">competitors</font>;       ·        quarterly  <font color="blue">variations</font>  in  our or our <font color="blue">competitors</font>’ results of     <font color="blue">operations</font>;       ·        failure  to achieve operating results projected <font color="blue">by securities</font>     analysts;       ·       failure to achieve operating results <font color="blue">within guidance provided by</font> our     senior <font color="blue">management</font>;       ·       changes in earnings estimates or recommendations <font color="blue">by securities</font>     analysts;       ·       changes in <font color="blue">management</font>;       ·       changes in investors’ beliefs as to the <font color="blue">appropriate</font> valuation ratios     for us and our <font color="blue">competitors</font>;       ·        investors’ <font color="blue">perception</font> that we have not <font color="blue">validated parts</font> of our     business model;       ·       changes in investors’ levels of <font color="blue">risk aversion</font>;       ·       <font color="blue">speculation</font> in the press or <font color="blue">analyst community</font>;       ·       <font color="blue">development</font>s in our industry;       ·       changes in our <font color="blue">growth rates</font>; and       ·       general market <font color="blue">conditions</font>, political influences and other factors,     including <font color="blue">factors unrelated</font> to our operating performance or the operating     performance of our <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>21     ______________________________________________________________________       These factors and <font color="blue">fluctuations</font>, as well as general economic, political, and     market <font color="blue">conditions</font>, may <font color="blue">materially</font> <font color="blue">adversely</font> affect the <font color="blue">market price</font> of our     <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td><font color="blue">Securities </font>class action <font color="blue">litigation</font> is often brought against a     company  following  periods  of  <font color="blue">volatility</font> in the <font color="blue">market price</font> of its     securities</td>
    </tr>
    <tr>
      <td>We may in the future be the target of similar <font color="blue">litigation</font></td>
    </tr>
    <tr>
      <td><font color="blue">Securities </font> <font color="blue">litigation</font>, whether with or without merit, could result in     substantial costs and divert <font color="blue">management</font>’s attention and resources, which     <font color="blue">could harm</font> our business and <font color="blue">financial condition</font>, as well as the <font color="blue">market price</font>     of  our  common  stock</td>
    </tr>
    <tr>
      <td>Additionally, <font color="blue">volatility</font> or a lack of positive     performance in our stock price may <font color="blue">adversely</font> affect our ability to retain     <font color="blue">key employees</font>, most of whom have <font color="blue">been granted stock options</font></td>
    </tr>
    <tr>
      <td>We  <font color="blue">depend on</font> a limited number of suppliers and will be delayed in our     <font color="blue">manufacture</font> or unable to <font color="blue">manufacture</font> our <font color="blue">Symyx Tools </font>if <font color="blue">shipments from</font> these     suppliers are delayed or <font color="blue">interrupted</font>       Key parts of our <font color="blue">Symyx Tools </font>systems are <font color="blue">currently available only from</font> a     <font color="blue">single source</font> or a limited number of sources</td>
    </tr>
    <tr>
      <td>In addition, <font color="blue">components</font> of our     <font color="blue">capital equipment</font> are <font color="blue">available from one</font> or only a <font color="blue">few suppliers</font></td>
    </tr>
    <tr>
      <td>In the     event that <font color="blue">supplies from</font> these vendors are delayed or <font color="blue">interrupted</font> for any     reason, we may not be able to get equipment or <font color="blue">components</font> for <font color="blue">Symyx Tools </font>    systems or our own <font color="blue">research efforts</font> in a <font color="blue">timely fashion</font> or in sufficient     quantities or under acceptable terms</td>
    </tr>
    <tr>
      <td>Even  if  <font color="blue">alternative</font>  sources  of  supply  are available, it could be     time-consuming and expensive for us to <font color="blue">qualify new vendors</font> and integrate     their <font color="blue">components</font> into our <font color="blue">Symyx Tools </font>systems</td>
    </tr>
    <tr>
      <td>In addition, we are <font color="blue">dependent</font>     on our vendors to provide <font color="blue">components</font> of <font color="blue">appropriate</font> quality and <font color="blue">re<font color="blue">liability</font></font></td>
    </tr>
    <tr>
      <td>Consequently, in the event that <font color="blue">supplies from</font> these vendors were delayed or     <font color="blue">interrupted</font> for any reason, we could be delayed in our ability to develop     and deliver products</td>
    </tr>
    <tr>
      <td>Our <font color="blue"><font color="blue">investment</font>s</font> could lose market value and <font color="blue"><font color="blue">consequently</font> harm</font> our ability to     fund continuing <font color="blue">operations</font>       The <font color="blue">primary objective</font> of our <font color="blue">investment</font> <font color="blue">activities</font> is to <font color="blue">preserve principal</font>     while at the same time maximizing yields without <font color="blue">significant</font>ly increasing     risk</td>
    </tr>
    <tr>
      <td>To  achieve  this  objective, we maintain our portfolio of cash     <font color="blue">equivalents</font>,  short-term  and  long-term  <font color="blue"><font color="blue">investment</font>s</font>  in a variety of     securities, including <font color="blue">government</font> and <font color="blue">corporate obligations</font> and <font color="blue">money market</font>     funds</td>
    </tr>
    <tr>
      <td>These securities are generally classified as available-for-sale and     <font color="blue">consequently</font> are <font color="blue">recorded on</font> the <font color="blue">balance sheet at fair value with unrealized</font>     gains  or losses reported as a separate component of <font color="blue">accumulated</font> other     comprehensive income (loss), net of estimated tax</td>
    </tr>
    <tr>
      <td>The <font color="blue">market values</font> of     these  <font color="blue"><font color="blue">investment</font>s</font>  may  fluctuate  due to market <font color="blue">conditions</font> and other     <font color="blue">conditions</font> over which we have no control</td>
    </tr>
    <tr>
      <td><font color="blue">Fluctuations </font>in the <font color="blue">market price</font>     and <font color="blue">valuations</font> of these <font color="blue">securities may</font> require us to <font color="blue">record losses due</font> to     <font color="blue">impairment</font> in the value of the <font color="blue">securities underlying</font> our <font color="blue">investment</font></td>
    </tr>
    <tr>
      <td><font color="blue">This     </font>could result in <font color="blue">future charges on</font> our earnings</td>
    </tr>
    <tr>
      <td><font color="blue">Investments  </font>in  both  fixed  rate  and floating rate interest earning     <font color="blue">instruments</font>  carry  varying  degrees of interest rate risk</td>
    </tr>
    <tr>
      <td>Fixed rate     <font color="blue">securities may</font> have their fair market value <font color="blue">adversely</font> impacted due to a rise     in <font color="blue">interest rates</font></td>
    </tr>
    <tr>
      <td>In general, securities with longer maturities are subject     to <font color="blue">greater interest rate risk than</font> those <font color="blue">with shorter maturities</font></td>
    </tr>
    <tr>
      <td><font color="blue">Although  </font>   <font color="blue">floating rate securities generally</font> are subject to <font color="blue">less interest rate risk</font>     than fixed rate securities, floating rate <font color="blue">securities may</font> produce less income     than expected if <font color="blue">interest rates</font> decrease</td>
    </tr>
    <tr>
      <td>Due in part to these factors, our     <font color="blue">investment</font> income may fall short of <font color="blue">expectations</font> or we may suffer losses in     principal if securities are sold that have declined in market value due to     changes in <font color="blue">interest rates</font></td>
    </tr>
    <tr>
      <td>Changes in <font color="blue">accounting</font> standards regarding stock option plans have limited     the <font color="blue">desirability</font> of <font color="blue">granting stock options</font>, which may harm our ability to     attract and retain employees, reduce our <font color="blue">profitability</font> and may affect our     stock price       We are required to adopt SFAS Nodtta 123(R), Share-Based Payment, on January 1,     2006</td>
    </tr>
    <tr>
      <td>This statement requires us to treat the value of <font color="blue">stock options granted</font>     to <font color="blue">employees as</font> an expense</td>
    </tr>
    <tr>
      <td>The adoption of this       22     ______________________________________________________________________       <font color="blue">statement will reduce</font> the <font color="blue">attractiveness</font> of <font color="blue">granting stock options</font> because     the  <font color="blue">additional</font>  expense  <font color="blue">associated with</font> these <font color="blue">grants will reduce</font> our     <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>However, stock-based <font color="blue">compensation</font> is an <font color="blue">important employee</font>     <font color="blue">recruitment</font> and retention tool, and we may not be able to attract and retain     <font color="blue">key personnel</font> if we reduce the scope of our <font color="blue">employee stock programs</font></td>
    </tr>
    <tr>
      <td>We may     need to limit the use of stock-based <font color="blue">compensation</font> and continue to explore     other <font color="blue">compensation</font> plans to assist in employee <font color="blue">recruitment</font> and retention</td>
    </tr>
    <tr>
      <td>We     cannot determine how investors will view the change in <font color="blue">accounting</font> treatment     of stock-based <font color="blue">compensation</font> and the change in our practices and how these     changes  may impact our stock price and <font color="blue">perception</font> of the value of our     company</td>
    </tr>
    <tr>
      <td><font color="blue">Failure  </font>to  maintain  <font color="blue">effective</font>  <font color="blue">internal control</font>s in <font color="blue">accordance</font> with     Section 404 of the Sarbanes-Oxley Act could have a material adverse effect     on our business and stock price       Each  year  we  are required to document and test our <font color="blue">internal control</font>     procedures  in order to satisfy the <font color="blue">requirements</font> <font color="blue">of Section </font>404 of the     Sarbanes-Oxley Act, which requires annual <font color="blue">management</font> <font color="blue">assessments</font> of the     <font color="blue">effective</font>ness of our <font color="blue">internal control</font>s over financial reporting and a report     by  our In<font color="blue">dependent</font> Registered Public Accounting Firm <font color="blue">addressing</font> these     <font color="blue">assessments</font>  and  the <font color="blue">effective</font>ness of <font color="blue">internal control</font> over financial     reporting</td>
    </tr>
    <tr>
      <td>During the course of our testing we may identify <font color="blue">deficiencies</font>     that we are required to remediate in order to comply with the <font color="blue">requirements</font>     <font color="blue">of Section </font>404</td>
    </tr>
    <tr>
      <td>In addition, if we fail to maintain the adequacy of our     <font color="blue">internal control</font>s, as such standards are modified, supplemented or amended     from time to time, we may not be able to ensure that we can conclude on an     ongoing  basis that we have <font color="blue">effective</font> <font color="blue">internal control</font>s over financial     reporting  in  <font color="blue">accordance</font>  with Section 404 of the Sarbanes-Oxley Act</td>
    </tr>
    <tr>
      <td>Furthermore, there are <font color="blue">certain areas</font> of <font color="blue">accounting</font> such as <font color="blue">income tax</font> that     <font color="blue">involve extremely complex rules</font> that <font color="blue">vary by country</font>, where an innocent     error, not misconduct, could be deemed to be a <font color="blue">significant</font> deficiency or a     material weakness in our <font color="blue">internal control</font>s</td>
    </tr>
    <tr>
      <td>Failure to maintain an <font color="blue">effective</font>     <font color="blue">internal control</font> <font color="blue">environment</font> could have a material adverse effect on our     stock price</td>
    </tr>
    <tr>
      <td>If our products contain defects, it <font color="blue">could harm</font> our revenues and expose us to     <font color="blue">litigation</font>       The products we offer are <font color="blue">internally complex</font> and, despite extensive testing     and quality control, may contain errors or defects, especially when we first     <font color="blue">introduce them</font></td>
    </tr>
    <tr>
      <td>We may need to <font color="blue">issue corrective releases</font> of our software     products to fix any defects or errors</td>
    </tr>
    <tr>
      <td>Any defects or <font color="blue">errors could also</font>     cause injury to personnel and/or damage to our reputation and result in     increased costs, loss of revenues, product returns or order <font color="blue">cancellation</font>s,     or lack of market <font color="blue">acceptance</font> of our products</td>
    </tr>
    <tr>
      <td>Accordingly, any defects or     errors could have a material and adverse effect on our business, results of     <font color="blue">operations</font> and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>Our license <font color="blue">agreements</font> with our <font color="blue">customers typically contain provisions</font>     designed to limit our exposure to <font color="blue">potential <font color="blue">product <font color="blue">liability</font></font></font> claims</td>
    </tr>
    <tr>
      <td>It is     possible, however, that the <font color="blue">limitation</font> of <font color="blue"><font color="blue">liability</font> provisions contained</font> in     our license <font color="blue">agreements</font> may not be <font color="blue">effective</font> as a result of existing or     <font color="blue">future federal</font>, state or <font color="blue">local laws</font> or ordinances or <font color="blue">unfavorable judicial</font>     <font color="blue">decisions</font></td>
    </tr>
    <tr>
      <td>Although we have not experienced any <font color="blue">product <font color="blue">liability</font></font> claims to     date, sale and support of our <font color="blue">products entails</font> the risk of such claims,     <font color="blue">which could</font> be substantial in light of our customers’ use of <font color="blue">such products</font>     in mission-critical applications</td>
    </tr>
    <tr>
      <td>If a claimant brings a <font color="blue">product <font color="blue">liability</font></font>     claim against us, it could have a material adverse effect on our business,     results of <font color="blue">operations</font> and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">products interoperate</font>     with  many  parts of complicated <font color="blue">computer systems</font>, such as mainframes,     servers, personal computers, application software, databases, operating     systems and <font color="blue">data transformation software</font></td>
    </tr>
    <tr>
      <td>Failure of any one of these parts     could  cause  all  or large parts of <font color="blue">computer systems</font> to fail</td>
    </tr>
    <tr>
      <td>In such     <font color="blue">circumstances</font>, it may be <font color="blue">difficult</font> to determine which part failed, and it is     likely that <font color="blue">customers will bring</font> a <font color="blue">lawsuit against several suppliers</font></td>
    </tr>
    <tr>
      <td><font color="blue">Even     </font>if  our software is not at fault, we <font color="blue">could suffer</font> material expense and     material diversion of <font color="blue">management</font> time in defending any <font color="blue">such lawsuits</font></td>
    </tr>
    <tr>
      <td>23     ______________________________________________________________________       We are exposed to <font color="blue">general global economic</font> and market <font color="blue">conditions</font>       Our business is subject to the effects of general economic <font color="blue">conditions</font> in the     United  States, Europe, Asia, and globally, and, in particular, market     <font color="blue">conditions</font>  in  the  <font color="blue">pharmaceutical</font> and chemical <font color="blue">industries</font></td>
    </tr>
    <tr>
      <td>In recent     quarters, our ability to conclude <font color="blue">Symyx Tools </font>sale <font color="blue">agreements</font> and research     and <font color="blue">development</font> <font color="blue">collaborative</font> <font color="blue">arrangements</font> have been <font color="blue"><font color="blue">adversely</font> affected</font> as a     result of unfavorable economic <font color="blue">conditions</font> and <font color="blue">reduced capital spending</font> in     the United States, Europe, and Asia</td>
    </tr>
    <tr>
      <td>If the economic <font color="blue">conditions</font> in the     United States and globally do not improve, or if we experience a worsening     in the <font color="blue">global economic slowdown</font>, we may experience material <font color="blue">adverse impacts</font>     on our business, operating results, and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>We are exposed to risks <font color="blue">associated with</font> <font color="blue">export sales</font> and <font color="blue">operations</font> that may     limit our ability to <font color="blue">generate revenue from</font> our products and <font color="blue">intellectual</font>     property       We have recently established <font color="blue">operations</font> in <font color="blue">certain parts</font> of <font color="blue">Europe and Asia</font></td>
    </tr>
    <tr>
      <td>We intend to continue to expand our <font color="blue"><font color="blue">international</font> presence</font> in order to     increase our <font color="blue">export sales</font></td>
    </tr>
    <tr>
      <td>Export sales to <font color="blue">international</font> customers and     operating in foreign countries entail a number of risks, including:       ·       obtaining and enforcing <font color="blue">intellectual</font> <font color="blue">property rights</font> under a variety     of <font color="blue">foreign laws</font>;       ·       unexpected changes in, or <font color="blue">impositions</font> of, <font color="blue">legislative</font> or <font color="blue">regulatory</font>     <font color="blue">requirements</font>;       ·       delays resulting from <font color="blue">difficult</font>y in obtaining <font color="blue">export licenses</font> for     certain  <font color="blue">technology</font>, and tariffs, quotas, and other <font color="blue">trade barriers</font> and     <font color="blue">restrictions</font>;       ·       <font color="blue">longer payment cycles</font> and greater <font color="blue">difficult</font>y in <font color="blue">accounts receivable</font>     <font color="blue">collection</font>;       ·       <font color="blue"><font color="blue">potentially</font> adverse taxes</font>;       ·       currency exchange <font color="blue">fluctuations</font>;       ·       greater <font color="blue"><font color="blue">difficult</font>ies</font> in maintaining and enforcing US <font color="blue">accounting</font>     and public reporting standards;       ·       greater <font color="blue"><font color="blue">difficult</font>ies</font> in staffing and managing foreign <font color="blue">operations</font>;       ·       the burdens of <font color="blue">complying with</font> a variety of <font color="blue">foreign laws</font>; and       ·       other <font color="blue">factors beyond</font> our control</td>
    </tr>
    <tr>
      <td>We  are  also subject to <font color="blue">general <font color="blue">geopolitical</font> risks</font> in <font color="blue">connection with</font>     <font color="blue">international</font>  <font color="blue">operations</font>,  such  as  political,  social  and economic     instability, terrorism, potential hostilities, changes in diplomatic and     trade <font color="blue">relationship</font>s, and <font color="blue">disease outbreaks</font></td>
    </tr>
    <tr>
      <td>Although to date we have not     experienced any material adverse effect on our <font color="blue">operations</font> as a result of     such <font color="blue">regulatory</font>, <font color="blue">geopolitical</font> and other factors, we <font color="blue">cannot assure</font> investors     that <font color="blue">such factors will</font> not have a material adverse effect on our business,     financial  condition and operating results or require us to modify our     current business practices</td>
    </tr>
    <tr>
      <td>Any <font color="blue">inability</font> of ours to keep <font color="blue">pace with <font color="blue">technological</font> advances</font> and evolving     <font color="blue">industry standards would harm</font> our business       The market for our products is <font color="blue">characterized by continuing <font color="blue">technological</font></font>     <font color="blue">development</font>, evolving industry standards and changing customer <font color="blue">requirements</font></td>
    </tr>
    <tr>
      <td>Due to increasing <font color="blue">competition</font> in our field, it is likely that the pace of     innovation and <font color="blue">technological</font> change will increase</td>
    </tr>
    <tr>
      <td>Our <font color="blue">success depends</font> upon     our ability to <font color="blue">enhance existing products</font> and services and to respond to     changing  customer  <font color="blue">requirements</font></td>
    </tr>
    <tr>
      <td>Failure to develop and introduce new     products and services, or <font color="blue">enhancements</font> to existing products, in a timely     manner in response to changing market <font color="blue">conditions</font>, industry standards or     other customer <font color="blue">requirements</font> would harm our <font color="blue">future revenue</font>s and our business     and operating results</td>
    </tr>
    <tr>
      <td>24     ______________________________________________________________________       We use <font color="blue"><font color="blue">hazardous</font> materials</font> in our business, and any claims relating to     improper handling, storage or disposal of these <font color="blue">materials could</font> subject us     to <font color="blue">significant</font> <font color="blue">liabilities</font>       Our business involves the use of a <font color="blue">broad range</font> of <font color="blue"><font color="blue">hazardous</font> chemicals</font> and     materials</td>
    </tr>
    <tr>
      <td><font color="blue">Environmental </font><font color="blue">laws impose stringent civil</font> and <font color="blue">criminal penalties</font>     for improper handling, disposal and storage of these materials</td>
    </tr>
    <tr>
      <td>In addition,     in the event of an improper or <font color="blue">unauthorized release</font> of, or exposure of     <font color="blue">individuals</font> to, <font color="blue"><font color="blue">hazardous</font> materials</font>, we could be subject to <font color="blue">civil damages</font>     due to <font color="blue">personal injury</font> or <font color="blue">property damage</font> caused by the release or exposure</td>
    </tr>
    <tr>
      <td>A failure to comply with <font color="blue">environment</font>al laws could result in fines and the     revocation of <font color="blue">environment</font>al permits, <font color="blue">which could</font> prevent us from conducting     our business</td>
    </tr>
    <tr>
      <td>Accordingly, any violation of <font color="blue">environment</font>al laws or failure to     properly handle, store or dispose of <font color="blue">hazardous</font> <font color="blue">materials could</font> result in     <font color="blue">restrictions</font> on our ability to operate our business and could require us to     incur <font color="blue">potentially</font> <font color="blue">significant</font> costs for personal injuries, <font color="blue">property damage</font>     and <font color="blue">environment</font>al cleanup and <font color="blue">remediation</font></td>
    </tr>
    <tr>
      <td>Our  <font color="blue">facilities</font> are located near <font color="blue">known earthquake fault</font> zones, and the     occurrence of an earthquake or other <font color="blue">disaster could</font> cause damage to our     <font color="blue">facilities</font> and equipment and harm our business       Our <font color="blue">facilities</font> are located in the <font color="blue">Silicon Valley </font>near <font color="blue">known earthquake fault</font>     zones and are vulnerable to <font color="blue"><font color="blue">damage from</font> earthquakes</font></td>
    </tr>
    <tr>
      <td>In October 1989, a     <font color="blue">major earthquake</font> that caused <font color="blue">significant</font> <font color="blue">property damage</font> and a number of     <font color="blue">fatalities struck</font> this area</td>
    </tr>
    <tr>
      <td>We are <font color="blue">also vulnerable</font> to <font color="blue">damage from</font> other     types  of  <font color="blue">disasters</font>, including fire, floods, power outages or losses,     <font color="blue">communications failures</font> and similar events</td>
    </tr>
    <tr>
      <td>If any disaster were to occur,     our ability to operate our business at our <font color="blue">facilities</font> would be seriously, or     <font color="blue">potentially</font> <font color="blue">completely</font>, impaired</td>
    </tr>
    <tr>
      <td>In addition, the unique nature of our     research <font color="blue">activities</font> and of much of our <font color="blue">equipment could</font> make it <font color="blue">difficult</font> for     us to <font color="blue">recover from</font> a disaster</td>
    </tr>
    <tr>
      <td>We do not carry <font color="blue">earthquake insurance on</font> the     property that we own and the insurance we do maintain may not be adequate to     cover our losses resulting from <font color="blue">disasters</font> or other business <font color="blue">interruptions</font></td>
    </tr>
    <tr>
      <td>Accordingly, an earthquake or other disaster <font color="blue">could harm</font> our business and     operating results</td>
    </tr>
    <tr>
      <td>Some of our existing <font color="blue">stockholders</font> can exert control over us, and may not     make <font color="blue">decisions</font> that are in the <font color="blue">best interests</font> of all <font color="blue">stockholders</font>       Our  officers,  <font color="blue">directors</font>  and principal <font color="blue">stockholders</font> (greater than 5prca     <font color="blue">stockholders</font>) together control approximately 37prca of our <font color="blue">outstanding common</font>     stock</td>
    </tr>
    <tr>
      <td>As a result, these <font color="blue">stockholders</font>, if they act together, will be able     to exert a <font color="blue">significant</font> degree of influence over our <font color="blue">management</font> and affairs     and over matters requiring stockholder approval, including the election of     <font color="blue">directors</font>  and  approval  of  <font color="blue">significant</font> corporate <font color="blue">transactions</font></td>
    </tr>
    <tr>
      <td><font color="blue">This     </font><font color="blue">concentration</font> of <font color="blue">ownership may</font> have the effect of delaying or preventing a     change in control of Symyx and might affect the <font color="blue">market price</font> of our common     stock,  even  when  such  a change may be in the <font color="blue">best interests</font> of all     <font color="blue">stockholders</font></td>
    </tr>
    <tr>
      <td><font color="blue">Provisions </font>of our charter <font color="blue">documents</font> may have anti-takeover effects that     could prevent a change in our control, even if this would be <font color="blue">beneficial</font> to     <font color="blue">stockholders</font>       <font color="blue">Provisions </font>of our amended and restated <font color="blue">certificate</font> of <font color="blue">incorporation</font>, bylaws     <font color="blue">and Delaware </font>law could make it more <font color="blue">difficult</font> for a <font color="blue">third party</font> to acquire     us,  even  if  doing so would be <font color="blue">beneficial</font> to our <font color="blue">stockholders</font></td>
    </tr>
    <tr>
      <td><font color="blue">These     </font>provisions include:       ·       a classified Board of Directors, in which our board is divided into     three classes with three-year terms with only one class elected at each     annual meeting of <font color="blue">stockholders</font>, which means that a holder of a majority of     our <font color="blue">common stock</font> will need <font color="blue">two annual meetings</font> of <font color="blue">stockholders</font> to gain     control of the Board;       ·       a provision which prohibits our <font color="blue">stockholders</font> from acting by written     consent without a meeting;       25     ______________________________________________________________________       ·       a provision which permits only the Board of Directors, the President     or the Chairman to call special meetings of <font color="blue">stockholders</font>; and       ·       a provision which requires advance notice of items of business to be     brought before <font color="blue">stockholders</font> meetings</td>
    </tr>
    <tr>
      <td>These provisions can be <font color="blue">amended only with</font> the vote of the holders of 66 2/3prca     of our <font color="blue">outstanding capital stock</font></td>
    </tr>
  </tbody>
</table>